Английская Википедия:ETH-LAD

Материал из Онлайн справочника
Версия от 09:03, 1 марта 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{short description|Chemical compound}} {{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 414446334 | IUPAC_name = (6a''R'',9''R'')-''N'',''N''-diethyl-7-ethyl-4,6,6a,7,8,9-<br>hexahydroindolo-[4,3-''fg'']quinoline-9-carboxamide | image = ETH-LAD_structure.png | width = 200 <!--Clinical data--> | tradename = | legal_AU = | legal_CA = | legal_DE = Np...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Infobox drug

ETH-LAD, 6-ethyl-6-nor-lysergic acid diethylamide is an analogue of LSD. Its human psychopharmacology was first described by Alexander Shulgin in the book TiHKAL. ETH-LAD is a psychedelic drug similar to LSD, and is slightly more potent than LSD itself,[1] with an active dose reported at between 20 and 150 micrograms. ETH-LAD has subtly different effects to LSD, described as less demanding. The true tryptamine counterpart of ETH-LAD is MET, a simplified version of this structure.

Legality

On June 10, 2014, the UK Advisory Council on the Misuse of Drugs (ACMD) recommended that ETH-LAD be specifically named in the UK Misuse of Drugs Act as a class A drug despite not identifying it as ever having been sold or any harm associated with its use.[2] The UK Home office accepted this advice and announced a ban of the substance to be enacted on 6 January 2015.[3]

ETH-LAD is illegal in Switzerland as of December 2015.[4]

See also

References

Шаблон:Reflist

Further reading

Шаблон:Refbegin

Шаблон:Refend

External links

Шаблон:Hallucinogenic lysergamides Шаблон:Serotonergics Шаблон:Ergolines


Шаблон:Hallucinogen-stub